Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Non-cancer trials contact form
Phone: 800-664-4542 (toll-free)
International patient clinical studies questions
Tab Title Description
The purpose of this study is to explore patients' comfort levels in disclosing sexual orientation and gender identity (SO/GI) in cancer care settings, aiming to assess current question formats, identify barriers, propose solutions, and develop a standardized questionnaire for clinical trial settings. Hypothesizing that patients, regardless of LGBTQ+ status, may exhibit diverse perspectives on SO/GI questions, the research aims to offer insights for more inclusive healthcare practices. Through quantitative and qualitative analysis, the study aims help addressing healthcare disparities among sexual and gender minority (SGM) individuals and provide a standardized approach for SO/GI data collection that is crucial for tailored interventions in clinical trials.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Exclusion Criteria:
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 5/8/2024. Questions regarding updates should be directed to the study team contact.
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic principal investigator
Elizabeth Cathcart-Rake, M.D.
Closed-enrolling by invitation